Cheyne Capital Management (UK) LLP - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 119 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.68 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cheyne Capital Management (UK) LLP ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$421,000
-45.9%
80,000
-19.2%
0.14%
-66.7%
Q4 2015$778,000
-58.2%
99,000
-55.1%
0.42%
-51.8%
Q3 2015$1,863,000
-51.5%
220,618
-37.1%
0.87%
-29.6%
Q2 2015$3,841,000
-43.1%
350,604
-27.5%
1.24%
-23.7%
Q1 2015$6,754,000
-2.4%
483,262
+18.0%
1.63%
-10.5%
Q4 2014$6,922,000
+57.7%
409,715
+25.4%
1.82%
+16.4%
Q3 2014$4,388,000
+187.2%
326,821
+172.4%
1.56%
-11.5%
Q2 2014$1,528,000
+7.1%
120,0000.0%1.77%
+29.1%
Q1 2014$1,427,000120,0001.37%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
BVF INC/IL 6,353,645$7,561,0000.31%
SPHERA FUNDS MANAGEMENT LTD. 1,476,000$1,756,0000.24%
EAM Investors, LLC 840,556$1,000,0000.22%
Gratus Capital, LLC 1,249,248$1,487,0000.16%
Ally Bridge Group (NY) LLC 86,242$103,0000.07%
MARINER INDEPENDENT ADVISOR NETWORK, LLC 1,252,822$1,491,0000.06%
Bleichroeder LP 250,000$298,0000.06%
GSA CAPITAL PARTNERS LLP 324,784$386,0000.05%
Polar Capital Holdings Plc 5,000,000$5,950,0000.04%
PLATINUM INVESTMENT MANAGEMENT LTD 545,508$649,0000.03%
View complete list of INFINITY PHARMACEUTICALS INC shareholders